Integer Holdings Corporation (ITGR) exhibits 27.0% gross margins and 6.0% return on invested capital within Health Care (Biotechnology: Electromedical & Electrotherapeutic Apparatus), balanced against a 18.3x enterprise multiple and 7.0% implied options volatility.
Sustained 27.0% gross profitability converts into 11.9% operating margin and 6.0% ROIC, outpacing sector cost of capital.
ROIC: 6.0% // GM: 27.0%YoY revenue trajectory of +8.0% paired with 2.44% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +8.0% // FCF YLD: 2.44%Altman Z-Score of 2.91 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.91 // F-SCORE: 7/9Trading at 41.8x trailing P/E (38.9x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 41.8x // EV/EBITDA: 18.3xOptions market prices a ±7.0% implied move with a 0.73 put/call ratio around $124.00 max pain.
IMPL MOVE: ±7.0% // P/C: 0.73Elevated industry capital intensity and customer concentration in Biotechnology: Electromedical & Electrotherapeutic Apparatus require continuous execution to defend 5.5% net margins.
NET MARGIN: 5.5% // D/E: 0.68x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ITGR & activate live FRED threshold breach alerts.